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Abstract
Microbial communities play vital roles in many aspects of our lives, although our understanding of microbial biogeography and community profiles remains unclear. The number of microbes or the diversity of the microbes,
even in small environmental niches, is staggering. Current microbiological methods used to analyse these communities are limited, in that many microorganisms cannot be cultured. Even for the isolates that can be cultured, the
expense of identifying them definitively is much too high to be practical. Many recent molecular technologies,
combined with bioinformatic tools, are raising the bar by improving the sensitivity and reliability of microbial
community analysis. These tools and techniques range from those that attempt to understand a microbial community from their length heterogeneity profiles to those that help to identify the strains and species of a random
sampling of the microbes in a given sample. These technologies are reviewed here, using the microbial communities present in the lungs of cystic fibrosis patients as a paradigm.
Keywords: amplicon length heterogeneity (LH), LH-PCR, bioinformatics, supervised machine learning, support vector
machines, T-RFLP, sequencing, pyrosequencing, 454 sequencing

Introduction
Microbial communities play important roles in
agriculture, bioremediation, and animal and
human health, although our understanding of
microbial biogeography and community profiles
remains unclear. Current microbiological methods
used to analyse these communities are limited, in
that many microorganisms cannot be cultured or
definitively identified. The application of recent
molecular and bioinformatics tools is improving
the sensitivity and reliability of microbial community analysis. These tools range from those using a
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‘broad brush strokes’ approach to shed light on a
microbial community profile to those involving
identification of the strains and species of a
random sampling of the microbes in a sample. The
environmental genome shotgun survey of the
Sargasso Sea1 highlights the tremendous microbial
diversity present in nature and the enormity of the
effort needed to assess diversity and to understand
a meta-community. This review discusses these
technologies in the context of analysing the
microbial communities present in the lungs of
cystic fibrosis (CF) patients.
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CF
CF is a fatal inherited disease primarily affecting
Caucasians. In the USA, 3,500 children are born with
the disease each year.2 The gene responsible for CF
encodes a protein called the CF transmembrane conductance regulator (CFTR).3 The CFTR is a
secretory epithelial cyclic-AMP-activated chloride
channel; mutations in the CFTR lead to decreased
fluid secretion and dehydration of epithelial surfaces.4
Oversecretion of thick mucus in the airway leads to
congestion of the respiratory tract and increased susceptibility to chronic broncho-pulmonary infection,
which is the major cause of morbidity and mortality
among patients with CF.4 To retard the rate of decreasing lung function, bacterial infections are treated with
antibiotics; however, these must be tailored to the particular infection, which is often polymicrobial. For
example, anti-pseudomonal drugs are often ineffective
for patients treated for Burkholderia cenocepacia infection
owing to resistance.5 Thus, it is important to identify
the infecting pathogens correctly in order to prescribe
an appropriate antibiotic regimen.
CF sputum bacterial flora
Staphylococcus aureus, Haemophilus influenzae and
Pseudomonas aeruginosa are the primary pathogens
found in the polymicrobial infection of CF
patients.6 Other opportunistic pathogens have also
emerged, such as B. cenocepacia, Alcaligenes xylosoxidans, Ralstonia pickettii, Burkholderia gladioli,
Stenotrophomonas maltophilia and Mycobacterium
species.6,7 S. aureus, the predominant pathogen in
children, is succeeded by H. influenzae during early
childhood, and P. aeruginosa becomes the predominant pathogen during adolescence, reaching a
prevalence rate of 80 per cent in adults.8 The
occurrence of the more recently emerging organisms increases with advancing age and severity of
lung disease.8,9
Common assays used for clinical identification
of bacteria and their limitations
Currently, the pathogens present in a CF sputum
sample, throat swab or bronchoalveolar lavage
(BAL) fluid are determined based on commercially

available culture-based biochemical and phenotypic identification systems. These systems can either
be manual, such as the API 20 NE (BioMérieux,
Marcy l’Etoile, France) or fully or partly automated, such as MicroScan (Dade Behring, West
Sacramento, CA, USA), BD Phoenix (Becton
Dickinson, Sparks, MD, USA), and VITEK
(BioMérieux).10 These systems allow clinical
microbiologists to identify bacteria accurately and
rapidly, ultimately leading to better and more costeffective patient management.11 Misdiagnosis
results from the limitation of the system’s reference
database10 or from strain variation.12 Since only
about 1 per cent of eubacteria in the environment
can be cultured,13 – 15 a number of pathogenic
species that are potentially present in the CF lung
can be missed.16 With other bacterial species (eg
Mycobacterium), even though they can be cultured,
due to their slow growth and similar phenotypes
they can still be easily misdiagnosed.17
Misidentification problems can be reduced or
completely eliminated by using genotype-based
molecular identification methods.18

Molecular analysis of isolates
In the CF lung, some bacteria can be identified
through culture whereas others would require molecular analysis. Molecular-based assays using polymerase chain reaction (PCR) and molecular
markers such as 16S rRNA have been designed to
identify pure isolates of many types of bacteria,
including Mycobacterium, and will be discussed in
detail.

PCR
PCR amplifies template material from minimal
amounts of extracted DNA.19,20 This technique
heralded a new era for the detection and identification of various microorganisms in any samples.
Thus, the most recent techniques that study microorganisms are molecular based, using both universal
and species-specific primers to select molecular
markers.19
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Molecular marker 16S ribosomal RNA
(rRNA)
rRNA plays a catalytic role in protein synthesis.
The basic ribosome structure is evolutionarily
conserved, although variations in overall proportions and sizes of RNA and protein
exist.21,22 A component of the small ribosomal
subunit, 16S rRNA, is composed of alternating
evolutionarily conserved and variable regions,23
and is the most commonly used molecular
marker.24 The conserved regions in 16S rRNA
(Figure 1) can be used to link organisms to
their distant ancestors, while the highly variable
regions can be used to identify evolutionary
relationships between closely related organisms,
at the genus and species level.23 Studying these
evolutionary relationships, however, requires the
sequencing of the 16S rRNA gene.

Mycobacterium spp. identification
DNA-based commercial assays have been developed
to
identify
slow-growing
Mycobacteria.
Mycobacterium tuberculosis can be identified using the
Cobas Amplicor assay, which is based on DNA
hybridisation of a fragment of the 16S rRNA
gene.25 Hain Lifescience (Baden-Württemberg,
Germany) developed a genotype Mycobacteria
direct assay for the detection of M. tuberculosis
complex and four atypical Mycobacteria.25 This
technique uses nucleic acid sequence-based amplification of the 23S rRNA gene. The MicroSeq
system (Applied Biosystems, Foster City, CA, USA)
is able to identify many Mycobacterium species based
on the first 500 base pairs of the 16S rRNA
gene.25,26 The most used identification method is
AccuProbe (Gen-Probe, San Diego, CA, USA).
Isolates are grown either in solid or liquid cultures.

Figure 1. Schematic representation of the variable and conserved regions of the 16S rRNA genes, using Escherichia coli rrsA
(ECDH10B_4040) as a reference. The diagram illustrates the approximate positions of nine variable (V) regions that are interspersed
with conserved regions. LH-PCR primer sequences for the conserved regions are included. The 8 F, 112 F/R, 338 F/R, 518 F/R and
785 F/R primers have also been referred to as 27 F, P2, 355 F/R, 536 F/R and 802 F/R, respectively. F and R refer to forward and
reverse, respectively. The degenerate nucleotides M, R, S, W and Y stand for A/C, A/G, G/C, A/T and C/T, respectively.
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The cells are lysed using sonication and labelled
DNA probes bound to the targeted rRNA. The
resulting light emission is measured, thus identifying
the isolate based on the DNA probe used in the
experiment.25 The emergence of non-tuberculous
mycobacteria in CF and immunocompromised
patients has created a need to assure accurate identification of these organisms. The sensitivity and
accuracy of each of these assays and others vary,
based on the species of Mycobacteria being analysed. These assays all rely on the isolation of bacteria and are not used to identify complex samples.
A sample containing two types of bacteria can
be analysed using matrix-assisted laser desorption
ionisation–time of flight mass spectrometry
(MALDI-TOF-MS).27,28 This method identifies cultivated organisms based upon the profile of proteins
and peptides detected from the bacteria. In one study,
CF-associated bacteria were analysed using
MALDI-TOF-MS.27 Each organism gave a specific
spectrum, irrespective of how the organism had been
grown (ie incubation time or media) or the presence
of a mucoidy phenotype. The authors concluded that
this identification technique is cost-effective, rapid
and easy to use. This technique, as mentioned earlier,
cannot be used to analyse complex communities.

Molecular tools for community
studies
Microbial diversity in complex microbial communities can be assessed based on the lengths of one
or more of the nine variable regions of 16S rRNA
(Figure 1). The PCR amplicons can be analysed
using other techniques, including: terminal restriction fragment length polymorphism (T-RFLP)
analysis and amplicon length heterogeneity
(LH).24,29 The fragments are separated and analysed
using a capillary electrophoresis-based genetic analyser. The data generated can be subjected to bioinformatics and statistical analysis to increase their
reliability. The resulting output can provide a community profile and can putatively identify individual organisms at the strain, species or genus level.
The recent developments in high-throughput
sequencing enable rapid sequencing of the

amplicons (bacterial and fungal, with the use of
appropriate primers), which is likely to lead to a
rapid understanding of the community structure of
any complex niche.

T-RFLP analysis
This technique relies on the inherent variation of
the sequence of a molecular marker30 and is the
most widely used method in identifying phylogenetic specificity in bacterial communities.31
T-RFLP analysis includes PCR amplification, using
one primer that is fluorescently end-labelled, restriction enzyme digestion of the amplicon and detection of the terminal restriction fragment by an
automated DNA sequencer or capillary electrophoresis.31 The resulting output consists of a microbial
profile where each detected length is that of specific
fragments from the digested PCR product. Each
length represents one or more bacteria that have the
same terminal restriction fragment length. T-RFLP
profiles can be used for community differentiation,
identification of specific organisms in populations
and comparison of the relative phylotype richness
and community structure.30
This method has been successful in the differentiation of bacterial communities present in many
environments, including marine samples, soil samples
and sputum samples from CF patients.30 – 33 Rogers
et al. 32 analysed T-RFLP amplicons of CF patient
sputa and bronchoscopy samples using a computer
program called MapSort (Wisconsin Package version
10.3; Accelrys, Inc., San Diego, CA, USA), which
contains a database containing restriction patterns
and lengths of fragments generated for known 16S
rRNA bacterial sequences. The analysis suggested
the presence of P. aeruginosa, B. cenocepacia, S. aureus,
and H. influenzae in the CF samples.32
The T-RFLP method is fast and data can be easily
replicated for statistical analysis. The major disadvantage of T-RFLP is that many bacteria produce similar
fragment sizes, and thus not all peaks in the profiles
are species specific. Some peaks may even represent
more than one genus.30,32 There are also inherent
problems in using restriction enzymes, such as
incomplete digestion, which can produce DNA
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fragments that do not correlate with the correct bacterium.33 Therefore, to achieve better identification
of the organism, further analysis — such as sequencing of the 16S rRNA gene — must be performed.
LH
LH techniques analyse microbial populations based
on the lengths of generated PCR products produced
from the hypervariable regions of the 16S rRNA.33 – 38
Profiles from one region are produced for the
microbial community. These profiles represent
the minimum diversity of bacteria present within the
eubacterial community. The profiles contain peaks at
specific amplicon lengths (Figure 2) representative of
the number of nucleotides in the hypervariable
region between the conserved regions. The peak
heights are representative of the relative abundance of
amplicons of that length present in the community.
To identify individual bacterial organisms in the
community, a database is needed. This can be generated by in silico analysis of known 16S rRNA
sequences and the expected amplicon fragment
length with a particular primer set that would be
produced during an LH-PCR. The fragment lengths
in the sample profile are compared against the database to identify the putative organisms. A profile
resulting from this analysis suggests the presence of
certain organisms and the definitive absence of
others. In cases where the amplicon length is not
species specific, it is often genus specific.29 LH profiles can also be used to compare community profiles
from multiple samples. Previous research has shown

Figure 2. A sample amplicon length heterogeneity
electropherogram using primers 8F and 338R. The x-axis
represents amplicon length in base pairs, and relative abundance
( proportional to intensity) is represented on the y-axis.
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that the compositions of bacterial communities are
highly specific to the environment in which they are
found, and these differences are represented in LH
profiles.33,35 Changes in the community’s niche can
drastically influence bacteria and thus add specificity
to the profile of a bacterial community, showing that
the overall bacterial community has many unique
features from sample to sample.33,35
The main advantages of LH-PCR are that it
rapidly surveys relative gene frequencies within
complex mixtures of DNA, is reproducible, requires
small sample sizes and can be performed simultaneously with many samples.29 The LH profiles
provide information about the members of the
entire bacterial community (not just specific isolates)
and their relative abundance. These data allow one
to make taxonomic inferences and sample comparisons.29 A major disadvantage of this technique is
that one amplicon in the profile can represent more
than one bacterium, therefore, identification at the
species level cannot be guaranteed. This is also true
with many length-based molecular techniques, such
as T-RFLP; however, the fragments are discrete
‘units’ of information that can be used for comparative analyses.30 Analysis of different combinations of
the 16S rRNA variable regions will increase the
power of microbial detection and sample discrimination and lead to more definitive identification.
LH was the first technique used in several ecological research projects to compare microbial communities between samples and to identify members
within one community.33,35,38 Fourteen CF sputum
samples were analysed using LH-PCR for the presence of eubacteria.32 The raw data generated from
the genetic analyser were first processed with corresponding software, such as GeneimageIR v.3.56
(Scanalytics, Fairfax, VA, USA.)32 or GeneMapper
(Applied Biosystems),35 to produce amplicon fragment lengths in base pairs. To identify presumptively
the bacteria present in the CF samples, the fragment
lengths were compared with a database of theoretical
fragment lengths constructed using GAP (Wisconsin
Package version 10.3).32 For example, P. aeruginosa
was identified presumptively in all 14 CF samples,
five of which were confirmed by cloning and
sequencing.32 In another study, LH analysis
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presumptively identified P. aeruginosa in 19 south
Florida CF patients, all of which were clinically diagnosed with this pathogen.39 The LH fragment representing B. cenocepacia was not found in any of the
patients, and clinical diagnosis and sequencing results
confirmed the absence of this organism.39
To assist in the identification of individual
microbial organisms in a community, we developed a
software package called AmpliQué, to be used in
conjunction with LH-PCR.39 For all the bacterial
and archaeal 16S rRNA sequences available from the
Ribosomal Database Project (RDP) (http://rdp.cme.
msu.edu/), AmpliQué computes the length of the
amplicon for any specified (degenerate) primer
sequence pair. For a given sample on which PCR
has been performed with a fixed pair of primers, and
given the lengths of the PCR products, AmpliQué
infers the bacterial and archaeal organisms present in
the sample. AmpliQué has recently been generalised
also to handle lengths of PCR products from more
than one pair of primers, enhancing the power of this
in silico identification method. AmpliQué was used to
determine the presumptive identity of organisms
present in 19 south Florida CF patients based on
the fragment lengths produced by LH-PCR. Oralassociated bacteria, such as Lactobacillus mali,
Capnocytophaga gingivalis, Porphyromonas spp. and
Prevotella spp. and the known CF-associated lung
pathogens P. aeruginosa, H. influenzae, B. cenocepacia,
Achromobacter xylosoxidans, Serratia marcesens, S. maltophilia and Sarcina ventriculi, were presumptively
identified.39
To expand the use of LH-PCR in clinical settings, Bjerketorp et al. 40 combined it with a
lab-on-a-chip (LOC) system, which is used for
sizing and quantifying DNA, to analyse samples
containing mixtures of known human gut
microbes. An Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA), a benchtop instrument that uses microfluidics-based separation, was used to detect the LH fragments. This
modified method allows LH-PCR to be more
affordable and faster, and thus more convenient and
suitable for clinical and diagnostic situations.40 To
test this system, samples containing mixtures of
human gut microbes and known human gut

bacteria isolates were analysed using both LOC and
a capillary electrophoresis-based genetic analyser.
The latter method had a higher resolution and was
thus able to resolve more peaks or fragments from
one another. It is important to separate PCR
fragments clearly, as LH identification is based on
the lengths of PCR products. Single base pair
length differences are known to occur between
species and even at the genus level. The level of
resolution for the LOC LH-PCR technique is a
weakness but the technique is rapid, economical
and easier to analyse than the traditional system.
Future modifications may improve the resolution,
making it more useful for clinical diagnosis.40

LH-related bioinformatics
Regardless of whether LH is being used to
compare communities or to identify members of a
community, statistics and bioinformatics must be
used to derive any information produced by the
technique. The first aspect of the LH-PCR system
is that it profiles a community based on the patterns
of lengths of amplified products (amplicons) and
allows one community to be distinguished among
other communities, without necessarily identifying
individual species or genera.
Microbial diversity and community dynamics were
first studied using computing measures, such as
species richness and dominance or evenness
indices.41 Theoretical models of microbial diversity
based on the log-normal distributions have also
been used.42 LH and T-RFLP data derived from
soil communities have been clustered using the
unweighted pair-group method using arithmetic
averages (UPGMA) algorithm based on the use of
distance metrics (such as the Jaccards, Hellinger or
Pearson distances).43 – 45 Such unsupervised methods
have been used to support claims that certain
relationships between communities can be discerned,
that the groupings are natural and that outliers can be
identified.
The statistical analysis of LH profiles is used to
differentiate between two or more microbial communities. Without rigorous statistical analysis, it is
impossible to differentiate between significant
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differences and random events. The identification
of individual organisms in the community will be
discussed later.

Statistical analysis based on ecological indices
Many statistical techniques have been applied to ecological indices that measure the diversity of microbial
communities. A number of diversity indices have
been used with microbial communities.41 Traditional
indices include the richness (S), the Shannon information index (H) and the evenness (E) derived from
it, and are defined as follows in Equations (1), (2) and
(3), respectively:
S ¼ number of peaks of in each sample
X
H¼
pi ðln pi Þ

ð1Þ
ð2Þ

i

where pi is the ratio of individual peak height to the
sum total of the heights of all the peaks in the LH
profile.
E¼

H
;
Hmax

SðRÞ ¼ ðST =½sð2pÞ0:5 Þe½R

2

=2s2 

;

where S(R) is the number of species that contain R
individuals, ST is the total number of species in the
community, and s 2 is the variance of the distribution. The parameters ST and s 2 can be estimated
from a sample of measured species abundance data by
using statistical techniques such as the method of
moments or least squares analysis.47

ð3Þ

where Hmax ¼ ln(S). Note that the traditional diversity indices are based on the clear definition of an
ecological description of an individual species. Here,
the definitions have been modified for presumptive
identification of LH profiles by replacing the definition of an individual species with that of individual
peaks in LH profiles.
Once appropriate diversity indices are chosen,
multivariate statistical techniques, such as analysis of
variance (ANOVA), can be applied to compare
microbial communities.

Statistical analysis based on abundance models
Even with the availability of the numerous diversity
indices, analysing microbial diversity and communities merely using ecological indices has its shortcomings.46 Although each index represents an
attempt to distil diversity information into a single
quantity, each one ends up measuring specific aspects
of diversity. Diversity indices vary in their sensitivity
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to different abundance classes. Species abundance
models are considered to be more sophisticated tools
to investigate diversity because they examine the distribution of abundances in a population.
Statistical models used for species abundance of
microbial communities include log series distribution, log-normal distribution,47 the broken stick
model and the overlapping niche model.41 The most
frequently used statistical model for species abundance distributions is the log-normal distribution.
In log-normal communities, the null model for bacterial species abundance is a log-normal distribution
defined as follows:

Supervised analysis of LH profiles
In addition to the unsupervised methods introduced
above, computational tools based on supervised classification methods from machine learning have also
been used for analyses based on microbial diversity.38
These methods are used to ‘learn’ the differences
between the diversities in the microbial communities
of two sets of samples. Two well-known supervised
classification tools include support vector machines
(SVM) and the k-nearest neighbour method (KNN).
These tools have the ability to ‘learn’ to classify
samples after being ‘trained’ with ‘features’ from a
collection of known, labelled samples. Both are computational machine-learning tools that treat the data
as points or vectors in Euclidean space. These vectors
are usually referred to as ‘feature vectors’ because
their coordinates correspond to quantified ‘features’
of the data. These features are usually obtained after a
feature extraction process. Given a new sample, it too
is represented by a feature vector. In both methods,
classification of the new sample is based on the
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location of its feature vector in relation to the
location of the labelled feature vectors in the feature
space.48 – 51 SVMs have been shown to perform well
in a variety of research areas, including pattern recognition,52 face recognition,53 classifications based on
microarray gene expression data,54 – 58 detecting
remote protein homologies59 and classifying
G-protein-coupled receptors.60 In particular, SVMs
are well suited for dealing with high-dimensional
data.48,51 KNN classifiers have been successfully used
in applications such as classification of handwritten
digits and satellite image scenes.50
Computational machine learning classifiers based
on SVMs and KNNs have been used to identify
and compare microbial communities from different
types of soil samples.38 After a learning phase, the
resulting classifiers were able to classify with high
accuracy. Detailed studies using these tools revealed
the limitations of the data and the minimum
amount of information from LH assays that was
necessary to perform reliable classification for
microbial communities.38

Sequencing
Even with the combined use of bioinformatics tools
and LH, certain members of a community may not
be identified. Sequencing of the 16S rRNA gene is
imperative to identify an organism with near certainty. The most common method of sequencing is
the Sanger method, developed in 1977.61 Once the
sequences are generated they are compared with
known 16S rRNA sequences (stored in the
Ribosomal Database Project II,62 Greengenes63 and
GenBank64) to identify organisms in any samples,
including the CF lung.10,65 Sequencing of the
RFLP-PCR products from the total metagenomic
DNA from BAL samples of CF children identified
known CF pathogens, such as P. aeruginosa, S.
aureus, S. maltophilia and H. influenzae. 65 Potentially
novel pathogens from the genera Lysobacter,
Coxiellaceae and Rickettsiales were also found.65
Another study which involved the sequencing of
the 16S rRNA gene has shown that CF sputum contains Streptococcus mitis, S. pneumoniae, Prevotella melaninogenica, Veionella spp., Granulicatella para-adiacens and

Exiguobacterium spp., besides the normal CF pathogens, such as P. aeruginosa. In this study, clones were
screened using LH-PCR to ensure that plasmids containing a wide array of 16S rRNA genes were
sequenced.
Although sequencing technologies are able to
identify bacteria in a sample more accurately, the
high cost of reagents and labour may be too expensive for widespread clinical use.66 For some bacteria,
partial sequencing of the gene would lead to identification; for others, the entire gene would need to be
analysed. Sequencing isolates can be performed in a
timely manner and the data produced are fairly easy
to analyse, especially with the use of commercial
sequencing kits;67 however, sequencing cannot
differentiate between some species (eg Mycobacterium
chelonae and M. abscessus are 99 per cent similar).66
Bacterial identification would still have to be
achieved using a polyphasic approach.
As with most molecular methods, non-culturable
bacteria can be sequenced but this requires
additional protocols, reagents and time. With traditional sequencing methods, cloning must be performed to isolate individual 16S rRNA genes
amplified by PCR. Even then, further screening
must be performed to ensure that multiple copies
of the same 16S rRNA gene are not repetitively
sequenced, thereby wasting time, reagents and
money. LH can be used as a screening method to
ensure that only clones of interest are sequenced.
Thus, efficient identification of non-isolates poses
many challenges.

Pyrosequencing
New developments in sequencing technologies are
revolutionising the way that microbial communities
are being studied.68,69 Recently developed pyrosequencing techniques that allow faster sequencing at
a lower cost are opening doors for many laboratories to use sequence data for microbial identification. Pyrosequencing relies on a process referred
to as sequencing-by-synthesis,70 a technique that
allows for real-time monitoring of DNA synthesis.71 Pyrosequencing is based on the principle
that pyrophosphate (PPi) is released when the
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DNA polymerase adds a nucleotide to the growing
complementary strand. The PPi is converted to
adenosine triphosphate (ATP), which is used as a
substrate in a chemical reaction that results in
visible light emission. The detectable amount of
light produced is relative to the amount of synthesis.71 As with the Sanger method, pyrosequencing can only sequence individual PCR products,
and thus must be used in conjunction with cloning
to study microbial communities.
Pyrosequencing has been used to identify bacterial
isolates by using the first and the third variable
regions of the 16S rRNA.72,73 Importantly, pyrosequencing surpassed traditional methods of detection
in a clinical setting by identifying 90 per cent of the
isolates at least at the genus level.74 The remaining 10
per cent of the isolates could not be identified owing
to the short sequencing reads, a clear drawback of
pyrosequencing.74 Pyrosequencing may help bacterial
identification in samples that do not lend themselves
to polyphasic approaches.75,76 This technique has also
been shown to distinguish clearly between multiple
species of Mycobacterium. Three species, Mycobacterium
kansasii, M. scrofulaceum and M. gordonae, require
further sequencing analyses to obtain accurate identifications.75 To implement pyrosequencing successfully as a diagnostic tool, the technique needs to be
improved to address its limitations. Bioinformatics
tools need to be refined or newly designed to handle
the large amounts of data. Also, further research
needs to be performed to validate the technique. In
addition, issues regarding management and use of
pyrosequencing in a clinical laboratory need to be
addressed.74

454 sequencing
This is a new technique which allows wholegenome sequencing in a matter of days. To circumvent the need for cloning, 454 sequencing, which
performs many PPi-sequencing reactions in parallel, was developed.77 The 454 sequencing combines
an emulsion-based method that isolates and amplifies DNA fragments in vitro with an instrument that
performs pyrosequencing in picolitre-sized wells.77
The reactions are resolved on a Genome Sequencer
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FLX (454 Life Sciences, Inc., Bradford, CT, USA),
which reads 200 – 300 bases and in one run can
read up to 400,000 bases.78 This method has been
used to study the microbial diversity of the deep
sea79 and the metagenome found in honey bees,
which led to the discovery of a possible causative
agent of colony collapse disorder.80 A large number
of microbial communities can be studied quickly
and efficiently with 454 sequencing.

Conclusion
The members of a microbial community and the
associated dynamics of the niche can be studied using
various methods. LH, T-RFLP and sequencing have
all been used to study microbial community profiles,
as well as to identify bacteria found in the CF lung.
Each of these techniques has its drawbacks but can
produce data that can be used (with the help of
bioinformatics) to understand the composition of the
community and the factors that drive it. Recent
advances in technology are now the driving force
behind community profiling. With the advances in
high-throughput sequencing-based technologies,
entire niches of organisms can be studied in a relatively short period of time. As a result, a vast amount
of complex data is produced from these experiments.
With the use of newly designed bioinformatics tools,
data can be interpreted correctly and provide
researchers with information that can ultimately be
used to address community interactions that dictate
the outcomes of human health studies.
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